Clinical Trial Update: Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma [NA]

View source ↗

Summary

This clinical trial update reports a completed study evaluating immunomonitoring for nivolumab with or without ipilimumab in metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Metastatic Melanoma | NA | Status: COMPLETED